[Sinovac: Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares March 8, 2019 BEIJING, – Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common ]
[Sinovac: Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares March 8, 2019 BEIJING, – Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common ]
[Semiconductor Manufacturing International Corporation Dr. Gao Yonggang Executive Director, Chief Financial Officer and Joint Company Secretary (Incorporated in the Cayman Islands with limited liability) SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION Notification of Approval of the Publication]
[Semiconductor Manufacturing International Corporation Dr. Gao Yonggang Executive Director, Chief Financial Officer and Joint Company Secretary (Incorporated in the Cayman Islands with limited liability) SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION Notification of Approval of the Publication]
[ChinaCache International Holdings Ltd. Announces BEIJING — March 11, 2019 First Nine Months of 2018 Financial Overview · Net revenues · Gross profit · Net income · Adjusted EBITDA In the first nine months of 2018, our strategy focused on core CDN services and related business, which is the main driv]
[ChinaCache International Holdings Ltd. Announces BEIJING — March 11, 2019 First Nine Months of 2018 Financial Overview · Net revenues · Gross profit · Net income · Adjusted EBITDA In the first nine months of 2018, our strategy focused on core CDN services and related business, which is the main driv]
[Sinovac: Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares March 8, 2019 BEIJING, – Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common ]
[] [Item 3.03 Material Modification to Rights of Security Holders. Company Amended and Restated Certificate Amendment of the Series D Certificate of Designation On March 11, 2019, the board of directors of China XD Plastics Company Limited (the “ (d) 3.1 Amendment of the Series D Certificate of Desig]
[Sinovac: Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares March 8, 2019 BEIJING, – Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common ]
[] [Item 3.03 Material Modification to Rights of Security Holders. Company Amended and Restated Certificate Amendment of the Series D Certificate of Designation On March 11, 2019, the board of directors of China XD Plastics Company Limited (the “ (d) 3.1 Amendment of the Series D Certificate of Desig]
